MARKET

UPC

UPC

UNIVERSE PHARMACEUTICALS INC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.380
-0.070
-4.83%
Pre Market: 1.460 +0.08 +5.80% 08:21 01/27 EST
OPEN
1.450
PREV CLOSE
1.450
HIGH
1.480
LOW
1.344
VOLUME
924
TURNOVER
--
52 WEEK HIGH
11.99
52 WEEK LOW
1.250
MARKET CAP
30.02M
P/E (TTM)
2.463
1D
5D
1M
3M
1Y
5Y
Universe Pharmaceuticals INC Announces Strategic Alliance With Jiangxi Province Institute Of Materia Medica To Conduct Research On Traditional Chinese Medicine
Ji'an, Jiangxi, China, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company had
Benzinga · 01/04 13:23
Universe Pharmaceuticals INC Announces Strategic Alliance with Jiangxi Province Institute of Materia Medica to Conduct Research on Traditional Chinese Medicine
Ji’an, Jiangxi, China, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into two strategic cooperation agreements ...
GlobeNewswire · 01/04 13:00
Universe Pharmaceuticals INC Announces Alliance With Jinggangshan University For Study On Chemical Constituents Of Certain Traditional Chinese Medicine
Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into a strategic cooperation agreement (the
Benzinga · 12/29/2021 13:04
26 Stocks Moving in Tuesday's Pre-Market Session
Gainers
Benzinga · 12/21/2021 11:55
Universe Pharmaceuticals names new COO
Universe Pharmaceuticals (NASDAQ:UPC) appointed Mr. Baochang Liu as its COO, effective Dec.1; Mr. Baochang Liu has 17+ years of experience in pharmaceutical marketing. Since 2019, he has been working as marketing and general manager of OTC
Seekingalpha · 12/15/2021 21:42
Universe Pharmaceuticals announces strategic alliance with Kitanihon
Universe Pharmaceuticals (NASDAQ:UPC) entered into a strategic cooperation agreement and associated ancillary agreements with Kitanihon Pharmaceutical, a Japanese company engaged in the research, development, manufacturing, and distribution of Kampo pharma...
Seekingalpha · 12/13/2021 14:06
Universe Pharmaceuticals reports 1H results
Universe Pharmaceuticals (NASDAQ:UPC): 1H GAAP EPS of $0.44. Revenue of $24.3M (+48.2% Y/Y) As of March 31, 2021, the Company had cash of $36.0M as compared to $10.1M as of
Seekingalpha · 08/02/2021 12:42
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2021
Ji’an, Jiangxi, China, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year...
GlobeNewswire · 08/02/2021 12:00
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of UPC. Analyze the recent business situations of UNIVERSE PHARMACEUTICALS INC through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About UPC
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.

Webull offers kinds of Universe Pharmaceuticals Inc stock information, including NASDAQ:UPC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UPC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading UPC stock methods without spending real money on the virtual paper trading platform.